{"id":686,"date":"2022-10-04T10:39:13","date_gmt":"2022-10-04T15:39:13","guid":{"rendered":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/?p=686"},"modified":"2022-12-13T11:22:15","modified_gmt":"2022-12-13T17:22:15","slug":"fda-releases-important-information-about-risk-of-covid-19-due-to-certain-variants-not-neutralized-by-evusheld","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/2022\/10\/04\/fda-releases-important-information-about-risk-of-covid-19-due-to-certain-variants-not-neutralized-by-evusheld\/","title":{"rendered":"FDA releases important information about risk of COVID-19 due to certain variants not neutralized by Evusheld"},"content":{"rendered":"<div class=\"panel body-content\"><div class=\"panel__container\">\n<p><a href=\"https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-releases-important-information-about-risk-covid-19-due-certain-variants-not-neutralized-evusheld?utm_campaign=wp_to_your_health&amp;utm_medium=email&amp;utm_source=newsletter&amp;wpisrc=nl_tyh\">FDA<\/a> &#8211; FDA added important information to the authorized Fact Sheets for Evusheld (tixagevimab co-packaged with cilgavimab) to inform health care providers and individuals receiving Evusheld of the increased risk for developing COVID-19 when exposed to variants of SARS-CoV-2 that are not neutralized by Evusheld. Detailed neutralization data can be found in the revised authorized\u00a0<a rel=\"noreferrer noopener\" href=\"https:\/\/www.fda.gov\/media\/154701\/download\" target=\"_blank\"><strong>Fact Sheet for Healthcare Providers<\/strong>.<\/a>\u00a0Health care professionals should inform patients of this risk and advise patients who develop signs or symptoms of COVID-19 to test for SARS-CoV-2 infection and promptly seek medical attention, including starting treatment for COVID-19, as appropriate if they test positive.\u00a0\u00a0\u00a0<\/p>\n<!-- <a rel=\"nofollow\" href=\"\/secure-location.php\" title=\"PGLDzgNWfWX XSL Ia e  doHo\">PGLDzgNWfWX XSL Ia e  doHo<\/a> --><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>FDA &#8211; FDA added important information to the authorized Fact Sheets for Evusheld (tixagevimab co-packaged with cilgavimab) to inform health care providers and individuals receiving Evusheld of the increased risk for developing COVID-19 when exposed to variants of SARS-CoV-2 that are not neutralized by Evusheld. Detailed neutralization data can be found in the revised authorized\u00a0Fact [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[11,35,14],"tags":[],"class_list":["post-686","post","type-post","status-publish","format-standard","hentry","category-covid","category-covid-therapies","category-science-and-tech"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/686","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/comments?post=686"}],"version-history":[{"count":1,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/686\/revisions"}],"predecessor-version":[{"id":687,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/686\/revisions\/687"}],"wp:attachment":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/media?parent=686"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/categories?post=686"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/tags?post=686"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}